The report covers ScinoPharm's performance in 2020, focusing on corporate governance, product responsibility, environmental protection, friendly work environment, and social responsibility. The company's key achievements include a 13% increase in gross profit, expansion of waste treatment capacity to 1,121 metric tons, reduction of waste liquid treatment by third parties by 66%, and investment of NT$ 5,985,000 in installing solar panels. The report also highlights ScinoPharm's commitment to ethical management, sustainable development, and promoting labor-management co-prosperity. The company also actively participates in charitable activities, supporting the arts and providing aid to disadvantaged groups.
Issuing Company ScinoPharm Taiwan Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 6.28 MB
No. of Pages 123 pages
Reporting periodJanuary 1, 2020-December 31, 2020
Report EditionUnknown
Assurance Provider PricewaterhouseCoopers (PwC) Taiwan
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue